Erratum to DYRK1A suppression restrains Mcl-1 expression and sensitizes NSCLC cells to Bcl-2 inhibitors.
- Published in:
- Cancer Biology & Medicine, 2022, v. 19, n. 7, p. 1109, doi. 10.20892/j.issn.2095-3941.2022.0172
- Publication type:
- Article
Works in Cancer Biology & Medicine, 2022, Vol 19, Issue 7
Results: 13
1
2
Feasibility of sentinel lymph node biopsy omission after integration of <sup>18</sup>F-FDG dedicated lymph node PET in early breast cancer: a prospective phase II trial.
- Published in:
- Cancer Biology & Medicine, 2022, v. 19, n. 7, p. 1100, doi. 10.20892/j.issn.2095-3941.2022.0085
- By:
- Publication type:
- Article
3
Fotemustine-based therapy in combination with rituximab as a first-line induction chemotherapy followed by WBRT for newly diagnosed primary central nervous system lymphoma: a prospective phase II trial.
- Published in:
- Cancer Biology & Medicine, 2022, v. 19, n. 7, p. 1089, doi. 10.20892/j.issn.2095-3941.2021.0026
- By:
- Publication type:
- Article
4
Microwave ablation vs. surgical resection for treatment naïve hepatocellular carcinoma within the Milan criteria: a follow-up of at least 5 years.
- Published in:
- Cancer Biology & Medicine, 2022, v. 19, n. 7, p. 1078, doi. 10.20892/j.issn.2095-3941.2020.0625
- By:
- Publication type:
- Article
5
Bilirubin inhibits the anticancer activity of sorafenib by blocking MCL-1 degradation in hepatocellular carcinoma cells.
- Published in:
- Cancer Biology & Medicine, 2022, v. 19, n. 7, p. 1061, doi. 10.20892/j.issn.2095-3941.2021.0598
- By:
- Publication type:
- Article
6
Dual-targeted lung cancer therapy via inhalation delivery of UCNP-siRNA-AS1411 nanocages.
- Published in:
- Cancer Biology & Medicine, 2022, v. 19, n. 7, p. 1047, doi. 10.20892/j.issn.2095-3941.2020.0416
- By:
- Publication type:
- Article
7
Identification of hub genes and their novel diagnostic and prognostic significance in pancreatic adenocarcinoma.
- Published in:
- Cancer Biology & Medicine, 2022, v. 19, n. 7, p. 1029, doi. 10.20892/j.issn.2095-3941.2020.0516
- By:
- Publication type:
- Article
8
IL13Rα1 prevents a castration resistant phenotype of prostate cancer by targeting hexokinase 2 for ubiquitin-mediated degradation.
- Published in:
- Cancer Biology & Medicine, 2022, v. 19, n. 7, p. 1008, doi. 10.20892/j.issn.2095-3941.2020.0583
- By:
- Publication type:
- Article
9
SY-1530, a highly selective BTK inhibitor, effectively treats B-cell malignancies by blocking B-cell activation.
- Published in:
- Cancer Biology & Medicine, 2022, v. 19, n. 7, p. 995, doi. 10.20892/j.issn.2095-3941.2020.0291
- By:
- Publication type:
- Article
10
ANTP-SMACN7 fusion peptide alone induced high linear energy transfer irradiation radiosensitization in non-small cell lung cancer cell lines.
- Published in:
- Cancer Biology & Medicine, 2022, v. 19, n. 7, p. 983, doi. 10.20892/j.issn.2095-3941.2020.0569
- By:
- Publication type:
- Article
11
Living biobank-based cancer organoids: prospects and challenges in cancer research.
- Published in:
- Cancer Biology & Medicine, 2022, v. 19, n. 7, p. 965, doi. 10.20892/j.issn.2095-3941.2021.0621
- By:
- Publication type:
- Article
12
Eliciting pyroptosis to fuel cancer immunotherapy: mechanisms and strategies.
- Published in:
- Cancer Biology & Medicine, 2022, v. 19, n. 7, p. 948, doi. 10.20892/j.issn.2095-3941.2022.0049
- By:
- Publication type:
- Article
13
Rosiglitazone disrupts pancreatic ductal adenocarcinoma progression by activating the tumor suppressor ESE3/EHF.
- Published in:
- Cancer Biology & Medicine, 2022, v. 19, n. 7, p. 945, doi. 10.20892/j.issn.2095-3941.2022.0299
- By:
- Publication type:
- Article